Stay updated on Phase 1 Study of Factor VIIa Variant (813d) in Hemophilia Clinical Trial
Sign up to get notified when there's something new on the Phase 1 Study of Factor VIIa Variant (813d) in Hemophilia Clinical Trial page.

Latest updates to the Phase 1 Study of Factor VIIa Variant (813d) in Hemophilia Clinical Trial page
- Check6 days agoChange DetectedNo significant additions or deletions were observed on the Study Details page; the page text and structure appear unchanged.SummaryDifference0.4%

- Check13 days agoNo Change Detected
- Check35 days agoChange DetectedAdded a prominent operating-status notice and a new v3.2.0 revision; removed the previous v3.1.0. This signals a status update and version upgrade.SummaryDifference2%

- Check42 days agoChange DetectedStandardizes a medical condition name to proper case and updates the revision version from v3.0.2 to v3.1.0.SummaryDifference0.1%

- Check56 days agoChange DetectedRevision updated from v3.0.1 to v3.0.2; the 'Back to Top' link was removed. No changes to pricing, stock, or other core content.SummaryDifference0.1%

- Check63 days agoChange DetectedThe web page has been updated from version 3.0.0 to version 3.0.1.SummaryDifference0.1%

- Check70 days agoChange DetectedThe web page has undergone significant updates, including the addition of specific facility names and locations in Turkey, Italy, and New Zealand, while also removing some previously listed locations and terms related to hemophilia.SummaryDifference5%

Stay in the know with updates to Phase 1 Study of Factor VIIa Variant (813d) in Hemophilia Clinical Trial
Enter your email address, and we'll notify you when there's something new on the Phase 1 Study of Factor VIIa Variant (813d) in Hemophilia Clinical Trial page.